Pharmacokinetics, pharmacodynamics, safety and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose-escalation study
收藏NIAID Data Ecosystem2026-03-14 收录
数据链接：
官方服务：
资源简介：
https://www.tandfonline.com/doi/full/10.1080/13543784.2023.2178894
创建时间：
2023-02-15
